The UMass Chan Diabetes Center of Excellence (DCOE) congratulates Doug Melton, PhD, who was awarded the Doctor Juan Abarca International Award for Medical Sciences for pioneering the process of converting stem cells into insulin-producing beta cells. Dr. Melton is the founder of Harvard’s Stem Cell and Regenerative Biology Laboratory. For over a decade, the UMass DCOE has collaborated with the Melton lab to further characterize these cells’ survival and function in our novel humanized mouse models. We share a common goal of protecting them from autoimmune attack.
Recent Posts
- The world’s first personalized gene therapy
- Nanoflowers rejuvenate old and damaged human cells by replacing their mitochondria
- CRISPR Gets an Invisibility Cloak
- The vital, overlooked role of body fat in shaping your health and mind
- Crispr gene-editing technology offers new hope for HIV cure but faces delivery challenges
- Vycellix Prepares for First-in-Human Study of Novel Allogeneic Cell Therapy Powered by Its Universal Cell Engineering Platform


